Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    New navigation options 'Check who can join' and 'Find Contact Information' were added to the page, and the revision label was updated from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T16:28:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.5) was added, superseding v3.5.4 on the page history. This reflects a software update to the page's revision-tracking system rather than a modification to the trial data.
    Difference
    0.1%
    Check dated 2026-06-05T11:57:48.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The history page now displays Revision: v3.5.4, replacing the former v3.5.3 and signaling a new UI/software revision for the page.
    Difference
    0.1%
    Check dated 2026-05-15T04:16:00.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 was added to the Record History. The previous revision v3.5.2 was removed from the list to reflect the latest changes to the study record.
    Difference
    0.1%
    Check dated 2026-04-30T17:48:41.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Version 44 adds Contacts/Locations, Study Design, and Study Status and updates the revision to v3.5.2; the previous revision v3.5.0 was removed on 2025-11-13.
    Difference
    0.4%
    Check dated 2026-04-16T10:28:40.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page now shows the latest revision as v3.5.0, replacing the previous v3.4.3. This updates the revision indicator without altering study data.
    Difference
    0.1%
    Check dated 2026-03-25T19:36:54.000Z thumbnail image

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.